Matching the Market for Heart Transplantation
Related Experiment Videos
1From the Heart and Vascular Institute at the Cleveland Clinic, OH; and Case Western Reserve University School of Medicine, Cleveland, OH. Hsiche@ccf.org.
Insights
Heart transplant waiting lists are growing, leading to deaths. Strategies to increase organ donors, reduce wait times, and improve allocation are crucial for patient survival.
Area of Science:
- Cardiology
- Transplantation Medicine
- Public Health
Background:
- Heart transplantation offers the best survival for end-stage heart failure, yet many patients die awaiting organs.
- The demand for heart transplants outpaces the stable donor supply, exacerbated by an aging recipient pool with increasing comorbidities.
- Certain demographics and conditions, including women, Hispanics, and those with restrictive or congenital heart disease, face higher mortality on the waiting list.
Purpose of the Study:
- To address the critical imbalance between heart transplant demand and donor availability.
- To explore strategies for increasing the donor pool, reducing the transplant waiting list, and optimizing organ allocation.
- To compare organ allocation strategies in the United States with those implemented internationally.
Main Methods:
- This review synthesizes current data on heart transplantation waiting lists and donor pools.
- It analyzes factors contributing to waitlist mortality, including patient demographics and disease types.
- Comparative analysis of organ allocation systems in the US versus other countries is presented.
Main Results:
- The number of heart transplant candidates has significantly increased while the donor pool remains stagnant.
- Specific patient groups, such as women and minorities, experience disproportionately higher waitlist mortality.
- Current allocation systems face challenges in efficiently matching available organs to suitable recipients.
Conclusions:
- Urgent interventions are required to expand the donor organ supply and streamline the allocation process.
- Addressing disparities in waitlist outcomes for vulnerable populations is essential.
- International comparisons may offer insights into optimizing heart transplant candidate management and resource allocation.
Abstract:
Heart transplantation is the most effective therapy for patients with Stage D heart failure with a median life expectancy of ≈10 to 15 years. Unfortunately, many patients die on the waiting list hoping for a chance of survival. The life boat cannot rescue everyone. Over a decade, the donor pool has remained relatively stable, whereas the number of heart transplant candidates has risen. Potential recipients often have many comorbidities and are older because the criteria for heart transplantation has few absolute contraindications. Women, Hispanics, and patients with restrictive heart disease and congenital heart disease are more likely to die while awaiting heart transplantation than men, white patients, and those with either ischemic or dilated cardiomyopathy. To better match the market, we need to (1) increase the donor pool, (2) reduce the waitlist, and (3) improve the allocation system. This review article addresses all 3 options and compares strategies in the United States to those in other countries.